Jim Cramer Blog

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
Gaps Down 5% or More: These are stocks that gap down by 5% or more and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that gap down by more than 5% have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Chemtura (NYSE:CEM - News). CEM's PowerRating is 7.
Laps Down 5% or More: These are stocks that lap down by 5% or more and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that lap down by more than 5% have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Micrus Endovascular (NasdaqGM:MEND - News). MEND's PowerRating is 8.
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Cache (NasdaqGS:CACH - News). CACH's PowerRating is 7.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Dollar General (NYSE:DG - News). DG's PowerRating is 6.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Johnson & Johnson (NYSE:JNJ - News). JNJ's PowerRating is 6..
Stocks Down 10% or More: These are stocks that have lost 10% or more over the past five days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that have lost 10% or more over the past five days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
U.S. Global Investors (NasdaqCM:GROW - News). GROW's PowerRating is 8.
Bearish
2-Period RSI Above 98: These are stocks that have a 2-period RSI reading above 98 and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving with a 2-period RSI reading above 98 have shown negative returns, on average, 1-day and 1-week later. Historically, these stocks have provided traders with a significant edge.
Fresh Del Monte Produce (NYSE:FDP - News). FDP's PowerRating is 3.
PowerRatings are courtesy of PowerRatings.net

Labels: CACH, CEM, DG, FDP, GROW, Hot Stocks, JNJ, MEND

Administaff (NYSE:ASF - News) said its fourth-quarter net income increased 22% to $13.4 million, or 47 cents a share, from $10.9 million, or 39 cents a share, a year earlier. The provider of human resources services said Monday revenue rose 15% to $352.6 million from $305.6 million. The company's average number of worksite employees paid per month advanced 11% and revenue per worksite employee per month rose 4.1%. Analysts surveyed by Thomson Financial, on average, expected the Houston company to earn 44 cents a share on revenue of $357.6 million for the final quarter of 2006. Administaff's board authorized the repurchase of up to 1 million more shares, bringing the total authorization to 9.5 million shares.
Arch Chemicals (NYSE:ARJ - News) reported a fourth-quarter loss of $28.3 million, or $1.18 per share, up from a year-ago profit of $3.6 million, or 15 cents a share. The latest results include a number of items, most notably an impairment charge of $23.5 million related to the write-down of goodwill associated with the company's industrial coatings business. Sales rose in the latest three months to $315.9 million from $278.3 million in the same period a year earlier. The average estimate of analysts polled by Thomson Financial was for loss of 9 cents a share in the December period. Looking ahead, the Norwalk, Conn.-based Arch said it expects earnings from continuing operations of $1.90 to $2 per share for fiscal 2007 with sales growth of 3% to 5%. For the first quarter, the company anticipates earnings from continuing operations of 10 to 15 cents a share. Wall Street's current consensus estimates are for earnings of $1.95 a share for 2007 and 30 cents a share for the March period.
Boston Scientific (NYSE:BSX - News) was downgraded by Bear Stearns to peer perform from outperform, as uncertainties about the drug-eluting stents market and competitive headwinds make sales growth and cost reductions difficult. Analyst Rick Wise said the fundamentals for the company's peers look better, and therefore he upgraded St. Jude Medical to outperform from peer perform, citing the company's strong product pipeline, its recent sales force investment and cost reduction opportunities.
Boyd Gaming Corp. (NYSE:BYD - News) was downgraded to market perform from outperform at Wachovia Securities.
Bristol-Myers Squibb (NYSE:BMY - News) and Sanofi-Aventis (NYSE:SNY - News) have reportedly scuttled merger talks, according to U.K. newspaper The Times (of London).
Calamos Asset Management Inc. (NasdaqGS:CLMS - News) said total assets under management as of Jan. 31 fell to $44.5 billion from $44.7 billion the previous month. The company said its mutual-fund assets fell to $33.1 billion from $33.3 billion, while separate-accounts held steady at $11.4 billion.
China BAK Battery Inc. (NasdaqGM:CBAK - News) reported fiscal first-quarter net earnings of $3.58 million, or 7 cents a share, up from $3.19 million, or 7 cents a share, in the year-ago period. Revenue in the three months ended Dec. 31 rose to $43.1 million from $26.1 million.
Chindex International (NasdaqCM:CHDX - News) shares fell after the provider of healthcare products and medical services in China reported a fiscal third-quarter net profit of $679,000, or 9 cents a share. In the same quarter last year, the company posted a net loss of $463,000, or 7 cents a share. Revenue rose to $30.3 million from $22.6 million.
Forward Air Corp. (NasdaqGS:FWRD - News) was downgraded to hold from buy at A.G. Edwards.
Eddie Bauer Holdings Inc. (NasdaqGM:EBHI - News) said its President and Chief Executive Fabian Mansson has resigned. The apparel retailer said Howard Gross, a member of the board, has been named interim CEO.
Embarq (NYSE:EQ - News) was downgraded to sell from neutral at Goldman Sachs.
Holly Corp. (NYSE:HOC - News) said fourth-quarter earnings rose to $47.7 million, or 84 cents a share, from $39.9 million, or 65 cents a share, a year earlier. Excluding discontinued operations, earnings would have increased to 86 cents a share from 63 cents a share. Analysts surveyed by Thomson Financial had been expecting earnings of 83 cents a share, on average. Revenue grew 15% to $938.1 million from last year's $812.4 million, with refined product volumes increasing 10%.
MedCath Corp. (NasdaqGM:MDTH - News) was downgraded to market perform from outperform at Wachovia Securities. "While we expect MedCath to grow faster than the rest of the hospital industry, we believe the market is already discounting that superior growth," Analyst William Bonello said in a research note. "Also, the threat of Medicare cuts to hospitals could keep a lid on multiples as the year progresses."
Micrus Endovascular (NasdaqGM:MEND - News) shares dropped after the San Jose, Calif.-based medical device maker reported a fiscal third-quarter net loss of $1 million, or 7 cents a share, compared with a net loss of $1.65 million, or 12 cents a share, in the year-ago period. Revenue rose to $15.5 million from $8.09 million.
Mercury General (NYSE:MCY - News) said fourth-quarter earnings rose 8.5% to $50.1 million, or 91 cents a share, from $46.2 million, or 84 cents, a year earlier. Analysts polled by Thomson Financial expected, on average, fourth-quarter earnings of $1.17 a share. The Los Angeles-based life insurance company said net realized investment gains increased to $1.34 million, or 2 cents a share, from $457,000, or a cent a share, in the year-ago period. Net premiums written rose to $740.7 million from $728 million, while net premiums earned rose to $753.9 million from $732.9 million.
Nam Tai Electronics Inc. (NYSE:NTE - News) posted a fourth-quarter loss of $2.3 million, or 5 cents a share, down from a year-ago profit of $12.7 million, or 29 cents a share. On a non-GAAP (generally accepted accounting principles) basis, excluding items, the company earned $12.3 million, or 28 cents a share, in the latest quarter. Sales fell 7.1% in the latest three months to $229.6 million from $247.2 million in the same period a year earlier. The average estimate of analysts polled by Thomson Financial was for a profit of 28 cents a share in the December period. The stock closed Friday at $14.26, down 14 cents.
The Nasdaq Stock Market (NasdaqGS:NDAQ - News) said it failed to secure sufficient support for its planned takeover of the London Stock Exchange.
Nuance Communications (NasdaqGS:NUAN - News) was downgraded to hold from buy at Needham & Co., which cited valuation concerns.
Rainmaker Systems (NasdaqGM:RMKR - News) said it plans to release its fourth-quarter results after the closing bell.
Shares of Sonic Automotive (NYSE:SAH - News) slumped after Bear Stearns downgraded the automotive retailer to peer perform from outperform, due primarily to valuation. Analyst Michael Geoghegan said that with the stock price closing in on his $33 price target, and with the valuation discount relative to its peers narrowing, he urged investors to "take profits."
Published By Michael Baron of MarketWatch

Labels: ARJ, ASF, BMY, BSX, BYD, CBAK, CHDX, CLMS, EBHI, EQ, FWRD, HOC, MCY, MDTH, MEND, NDAQ, NTE, NUAN, RMKR, SNY